Revaccination against the coronavirus infection will boost immune defense against the virus more than six-fold, Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry, said on Tuesday.
“After revaccination the immune system channels all its energy, all its forces to boost production of antibodies and, what is most important, for produce memory cells,” he said in an interview with the Dok-Tok program on TV Channel One.
“It makes it possible to develop a very strong, long-lasting immunity to the specific protein of the coronavirus, i.e. the corona protein, and hence, boost immune response, immune defense of a person by four, five, six and more times.”
On August 11, Russia registered the world’s first vaccine against the novel coronavirus. The vaccine, dubbed Sputnik V, was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry, and its clinical trials were successfully completed in June-July. The vaccine was developed on a platform that had been used for a number of other vaccines. According to the Russian health ministry, these vaccines have proved their ability to form lasting immunity for a period of up to two years.
The first batch of the vaccine is being currently delivered to Russian regions to inoculate medics, teachers and other employees working in close contact with people.
Header: MOSCOW, RUSSIA – AUGUST 14, 2020: A laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Russian Healthcare Ministry that produces a COVID-19 vaccine. The vaccine is to be produced at the institute and other Russian pharmaceutical plants. It will be available to general public on January 1, 2021. Vyacheslav Prokofyev/TASS